MedPath

Regional Anesthesia for Modified Radical Mastectomy With Axillary Lymph Node Dissection

Phase 3
Completed
Conditions
Breast Cancer
Interventions
Other: regional anesthesia
Registration Number
NCT04239716
Lead Sponsor
Tanta University
Brief Summary

local and regional anesthesia have been introduced with the goal of reducing the side effects associated with general anesthesia and IV opioid analgesia.our hypothesis is that ultrasound-guided interscalene brachial plexus block and erector spinae plane block will provide efficient surgical anesthesia and postoperative analgesia after modified radical mastectomy.

Detailed Description

inadequate analgesia after modified radical mastectomy with axillary lymph node dissection may occur with most of regional anesthesia. pain in the axilla and upper limb is related to ineffective block of medial and lateral pectoral nerves as long thoracic and thoracodorsal nerves, leading to inadequate analgesia.The aim of this study is to evaluate the efficacy and safety of ultrasound-guided interscalene brachial plexus block and erector spinae plane block for providing surgical anesthesia and postoperative analgesia after modified radical mastectomy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
13
Inclusion Criteria
  • Female patients aged 40-85 years old
  • American Society of Anesthesiologists' physical status III and IV
  • Planned for modified radical mastectomy with axillary lymph node dissection
Exclusion Criteria
  • Patient refusal
  • Neurological or psychiatric disorders
  • Local infection at injection site
  • Spine or chest wall deformity
  • Allergy or any contraindication to any of the study drugs
  • Opioid or alcoholic addiction
  • Chronic pain of any cause
  • Uncooperative patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
regional anesthesiaregional anesthesiacombination of erector spinae plane block (ESPB) and interscalene block(IB).the ESPB will be performed using linear ultrasound transducer (Philips® cx 50 extreme edition, USA) and we will inject 20 ml solution(10 ml 0.5% bupivacaine, 5 ml 2% lidocaine, and 5 ml normal saline). the IB will be performed using the same ultrasound machine and injecting the same solution
Primary Outcome Measures
NameTimeMethod
Success rate of the regional blocksfrom the start to the end of the operation

completion of the surgery without need of general anesthesia.

Secondary Outcome Measures
NameTimeMethod
Patients' satisfaction24-hours postoperative

degree of patients' satisfaction

duration of the blocks24- hours in the postoperative period

Time to first request of rescue analgesia postoperative

Any adverse events24-hours postoperative

postoperative nausea and vomiting, local anesthetic toxicity, desaturation, bradypnea,hypotension, bradycardia or somnolence

Trial Locations

Locations (1)

Tanta University, Faculty of Medicine

🇪🇬

Tanta, Egypt

© Copyright 2025. All Rights Reserved by MedPath